Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X, et al. Coronavirus susceptibility to the antiviral remdesivir (gs-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio. 2018;9(2):e00221–18.
Ahmad T, Khan M, Haroon Musa TH, Nasir S, Hui J, Rodriguez-Morales AJ (2020) COVID-19: Zoonotic aspects. Travel Med Infect Dis 36: 101607
Anderson TK, Macken CA, Lewis NS, Scheuermann RH, Van Reeth K, Brown IH, Swenson SL, Simon G, Saito T,Berhane Y, Ciacci-Zanella J, Pereda A, Davis CT, Donis RO, Webby RJ, Vincent AL (2016) A Phylogeny-Based global nomenclature system and automated annotation tool for H1 hemagglutinin genes from swine influenza A viruses. mSphere 1: e00275-16.
Asokan GV, Kasimanickam RK (2013) Emerging infectious diseases, antimicrobial resistance and millennium development goals: Resolving the challenges through one health. Cen Asian J Glob Health 2:76
Awaidy SA, Al Hashami H (2020) Zoonotic Diseases in Oman: Successes, Challenges, and Future Directions. Vector Borne Zoonot. Dis. 20(1): 1-9
Becerra JC, Bildstein LS, Gach JS (2016) Recent insights into the HIV/AIDS pandemic. Microb Cell 3:451–475
Bennett JE, Dolin R, Blaser MJ (2019) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 9th ed. Elsevier, Philadelphia; 3103-15
Bloom DE, Black S, Rappuoli R (2017) Emerging infectious diseases: A proactive approach, Proc Natl Acad Sci 114(16):4055-4059
Boni MF, Lemey P, Jiang X, Lam TT-Y, Perry B, Castoe T, Rambaut A, Robertson DL (2020) Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic. Nat. Microbiol 5:1408–1417
Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R (2020) Features, Evaluation and Treatment Coronavirus (COVID-19); StatPearls [Internet], StatPearls Publishing, Treasure Island (FL). https://www.ncbi.nlm.nih.gov/books/NBK554776/
Chen Y, Liu Q, Guo D (2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology 92(4): 418–423
Cheng LP, Wang TC, Yu R, Li M, Huang JW (2018) Design, synthesis and biological evaluation of novel zanamivir derivatives as potent neuraminidase inhibitors. Bioorganic & medicinal chemistry letters, 28(23-24): 3622-3629,
Cimarelli A, Darlix JL (2014) HIV-1 reverse transcription. Methods MolBiol 1087:55-70
Cunningham AA, Daszak P, Wood JLN (2017) One Health, emerging infectious diseases and wildlife: two decades of progress? Phil. Trans R Soc B 372: 20160167
Dammalli M, Chandramohan V, Biradar MI, Nagaraju N, Gangadharappa BS (2014) In silico analysis and identification of novel inhibitor for new H1N1 swine influenza virus. Asian Pac J Trop Dis 4:S635–S640
Eisinger RW, Fauci AS (2018) Ending the HIV/AIDS Pandemic. Emerg Infect Dis 24(3): 413–416
Eisinger RW, Dieffenbach CW, Fauci AS (2019) HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA 321(5):451–452
Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP (2019) Ending the HIV epidemic: a plan for the United States. JAMA 321(9):844–5
Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD (2015) Molecular docking and structure-based drug design strategies Molecules, 20(7):13384-13421,
Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M (2020) Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. J Biol Chem https://doi.org/10.1074/jbc.RA120.013679
Grace D, Gilbert K, Lapar L, Unger F, Fèvre F, Nguyen-Viet H, and Schelling E, (2011) Zoonotic Emerging Infectious Disease in Selected Countries in Southeast Asia: Insights from Eco health. Ecohealth J 8:55–62
He F, Deng Y, Li W (2020) Coronavirus disease 2019: What we know? Journal of Medical Virology 92(7): 719–725,
Henritzi D, Hoffmann B, Wacheck S, Pesch S, Herrler G, Beer M, et al. (2019) A newly developed tetraplex real-time RT-PCR for simultaneous screening of influenza virus types A, B, C and D. Influenza Other Respir Viruses 13:71-82.
Hung, K.K.C., Mark, C.K.M., Yeung, M.P.S. et al. (2018) The role of the hotel industry in the response to emerging epidemics: a case study of SARS in 2003 and H1N1 swine flu in 2009 in Hong Kong. Global Health 14: 117
Jacobson LE (2020) President's Emergency Plan for AIDS Relief (PEPFAR) Policy Process and the Conversation around HIV/AIDS in the United States. Journal of Development Policy and Practice. https://doi.org/10.1177/2455133320952210
Jayakanthan M, Chandrasekar S, Muthukumaran J, Mathur P P (2010) Analysis of CYP3A4-HIV-1 protease drugs interactions by computational methods for Highly Active Antiretroviral Therapy in HIV/AIDS. Journal of Molecular Graphics and Modelling 28:455–463
Jin L, Lamster I, Greenspan J, Pitts N, Scully C, Warnakulasuriya S (2016) Global burden of oral diseases: Emerging concepts, management and interplay with systemic health. Oral Dis 22: 609–619
Kazhila CC (2019)Chemical diversity and activity profiles of HIV-1 reverse transcriptase inhibitors from plants. RevistaBrasileira de Farmacognosia 29:504-28
Kilian M, Chapple I, Hannig M, Marsh P, Meuric V, Pedersen A, Tonetti M, Wade W, Zaura, E (2016). he oral microbiome–An update for oral healthcare professionals. Br Dent J 221:657–666
Lai, Y., Yan, Y., Liao, S. Li Y, Ye Y, Liu N, Zhao F, Xu P (2020) 3D-quantitative structure–activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase. Arch Pharm Re. 43: 489–502
Lewis NS, Russell CA, Langat P, Anderson TK, Berger K, Bielejec F, et al. (2016) ESNIP3 consortium. The global antigenic diversity of swine influenza A viruses. eLife 5: e12217.
Li JY, You Z, Wang Q, Zhou ZJ, Qiu Y, Luo R, Xing-Yi G (2020). The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes and Infection 22(2):80–85.
Liu SL, Saif L (2020) Emerging Viruses without Borders: The Wuhan Coronavirus. Viruses 12: 130
Marcus JL, Hurley LB, Nguyen DP, Silverberg MJ, Volk JE (2017) Redefining human immunodeficiency virus (HIV) preexposure prophylaxis failures. Clin Infect Dis 65(10):1768–9
Massinissa Si Mehand, Piers Millett, Farah Al-Shorbaji, Cathy Roth, Marie PauleKieny, Bernadette Murgue, World Health Organization Methodology to Prioritize Emerging Infectious Diseases, ww.cdc.gov/eid, Vol. 24, No. 9, September 2018.
Mehand MS, Al-Shorbaji F, Millett P, Murgue B (2018) The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts. Antivir Res 159:63–67
Mehand MS, Millett P, Al-Shorbaji F, et al. (2018) World Health Organization Methodology to Prioritize Emerging Infectious Diseases in Need of Research and Development. Emerg Infect Dis 24(9):e171427
Minardi da Cruz JC, Singh DK, Lamara A, Chebloune Y (2013) Small ruminant lentiviruses (SRLVs) break the species barrier to acquire new host range. Viruses 5:1867–84.
Monamele CG, Njifon HLM, Vernet M-A, Njankouo MR, Kenmoe S, Yahaya AA, et al. Molecular characterization of influenza A (H1N1) pdm09 in Cameroon during the 2014–2016 influenza seasons. PloS one. 14(1) e0210119.
Morens DM, Fauci AS (2020) Emerging pandemic diseases: how we got to COVID-19. Cell 182:1077–1092
Mugosa B, Vujosevic D, Ciccozzi M, Valli MB, Capobianchi MR, Lo Presti A, et al. (2016) Genetic diversity of the haemagglutinin (HA) of human influenza a (H1N1) virus in montenegro: Focus on its origin and evolution. Journal of medical virology. 88(11):1905–13. pmid:27088433
Nasr N, Alshehri AA, Wright TK, Shahid M, Heiner BM, Harman AN, Botting RA, Helbig KJ, Beard MR, Suzuki K et al. (2017) Mechanism of Interferon-Stimulated Gene Induction in HIV-1-Infected Macrophages. J Virol 91: e00744-17
Nii-Trebi NI (2017) Emerging and neglected infectious diseases: insights, advances, and challenges. BioMed Res Int 2017:5245021.
Pagadala NS, Syed K, Tuszynski J (2017) Software for Molecular docking: A review. Biophysical Reviews 9(2):91-102,
Phillips MA, Stewart MA, Woodling DL, Xie ZR (2014) Has Molecular Docking Ever Brought us a Medicine? In Molecular Docking. IntechOpen Limited p. 141, London, UK
Poorolajal J (2020) Geographical Distribution of COVID-19 Cases and Deaths Worldwide. J Res Health Sci 20(3): e00483
Pornillos O, Garrus JE, Sundquist WI (2020) Mechanisms of enveloped RNA virus budding. Trends Cell Biol 12: 569–579
Prashantha C, Gouthami K, Lavanya L, Bhavanam S, Jain A, Shakthiraju R, Suraj V, Sahana K, Sujana H, Guruprasad N (2021) Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of Coronavirus. Journal of Molecular Graphics & Modelling 102: 107769
Rueda S, Mitra S, Chen S, Gogolishvili D, Globerman J, Chambers L, et al. (2016) Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses. BMJ Open 6(7):e011453.
Sarafis P, Stavrakakis P, chalaris M, stamataki P, Zyga S, Saroglou G (2010), Emerging infectious diseases, Journal of Environmental Protection and Ecology 11: 917–929.
Schoeman D, Fielding BC (2019) Coronavirus envelope protein: current knowledge. Virol J 16: 69
Shajahan A, Heiss C, Ishihara M, Azadi P. Glycomic and glycoproteomic analysis of glycoproteins-a tutorial. Anal Bioanal Chem. 409:4483-4505, 2017.
Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, Geng Q, Auerbach A, Li F (2020) Structural basis of receptor recognition by SARS-CoV-2. Nature 581:221–224
Sk MF, Roy R, Kar P (2020) Exploring the potency of currently used drugs against HIV-1 protease of subtype D variant by using multiscale simulations. J. Biomol. Struct. Dyn
Smitha KM., Machalaba CC, Seifmanc R, Feferholtza Y, Karesha WB (2019).Infectious disease and economics: The case for considering multi-sectoral impacts, One Health 7:100080
Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R (2020) World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery 76: 71–76.
Taiaroa G, Rawlinson D, Featherstone L, Pitt M, Caly L, Druce J, Purcell D, Harty L, Tran T, Roberts J, Catton M, Williamson D, Coin L, Duchene S (2020) Direct RNA sequencing and early evolution of SARS-CoV-2. BioRxiv
Tang L, Bie B, Park S-E, Zhi D (2018) Social media and outbreaks of emerging infectious diseases: a systematic review of literature. Am J Infect Control 46: 962–972
Tarasova O, Poroikov V, Veselovsky, A (2018) Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review. Molecules,23(5). doi: 10.3390/molecules 23:1233
Townsend AK, Hawley DM, Stephenson JF, Williams KEG (2020) Emerging infectious disease and the challenges of social distancing in human and non-human animals, Proc R Soc B 287: 20201039
Valdiserri RO, Holtgrave DR (2019) Ending HIV in America: not without the power of community. AIDS Behav 23(11):2899–903
van Doorn HR (2014), Emerging infectious diseases, Medicine 42(1): 60–63
Velavan T P, Meyer CG (2020) The COVID-19 epidemic. Tropical Medicine & International Health 25(3): 278–280
Venkatramanan S, Lewis B, Chen J, Higdon D, Vullikanti A, Marathe M (2018) Using data-driven agent-based models for forecasting emerging infectious diseases. Epidemics 22:43-49
Viegi G, Maio S, Fasola S, Baldacci S (2020) Global burden of chronic respiratory diseases. J Aerosol Med Pulm Drug Deliv 33(4):171–177.
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30: 269–271
World Health Organization (2012) Developing Tools for Strategic Communication to the Media on Emerging Infectious Diseases (EIDs).Available online: http://apps.searo.who.int/PDS_DOCS/B4803.pdf
World Health Organization (WHO) (2020) WHO Statement Regarding Cluster of Pneumonia Cases in Wuhan, WHO, China. Beijing
World health statistics (2019) monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization. Licence: CC BY-NC-SA 3.0 IGO
Xie Q, He X, Yang F, Liu X, Li Y, Liu Y, Yang Z, Yu J, Zhang B, Zhao W (2018) Analysis of the Genome Sequence and Prediction of B-Cell Epitopes of the Envelope Protein of Middle East Respiratory Syndrome-Coronavirus. IEEE/ACM Trans. Comput. Biol. Bioinform 15:1344–1350
Yang Y, Du L, Liu C, Wang L, Ma C, Tang J, et al. (2014) Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proc Natl Acad Sci U S A.111(34):12516–21.
Yasuhara A, Yamayoshi S, Soni P, Takenaga T, Kawakami C, Takashita E, et al. (2017) Diversity of antigenic mutants of influenza A (H1N1) pdm09 virus escaped from human monoclonal antibodies. Scientific Reports 7(1):17735. pmid:29255273
Zhan P, Pannecouque C, De Clercq E, Liu X (2016) Anti-HIV drug discovery and development: current innovations and future trends. J Med Chem 59:2849-78
Zhu M, Dong B, Zhang GN, Wang JX, Cen S, Wang YC (2019) Synthesis and biological evaluation of new HIV-1 protease inhibitors with purine bases as P2-ligands. Bioorg Med Chem Lett. 29(12): 1541–1545
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–33